NTRK1 and neoplasm: However, fetal tumor and embryonal tumor organoids exhibited differential sensitivity to receptor tyrosine kinase inhibitors: embryonal organoids were sensitive to FGFR inhibitors, but fetal organoids responded to EGFR inhibitors.